SANJOSE wins Parc Taulí contract to refurbish Santa Fe building floor for outpatient, infectious disease day hospital use
Bitget2026/10/08 06:57Grupo Empresarial SANJOSE won a contract to refurbish and repurpose the second floor of the Santa Fe building at Parc Taulí University Hospital, Sabadell. Scope covers conversion of the “C” level for outpatient clinics and a day hospital for infectious diseases. The award was made by the Parc Taulí healthcare consortium. Project location: Barcelona province; contract date: Oct. 8, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grupo Empresarial SANJOSE SA published the original content used to generate this news brief on October 08, 2026, and is solely responsible for the information contained therein.
- Grupo Empresarial SANJOSE won a contract to refurbish and repurpose the second floor of the Santa Fe building at Parc Taulí University Hospital, Sabadell.
- Scope covers conversion of the “C” level for outpatient clinics and a day hospital for infectious diseases.
- The award was made by the Parc Taulí healthcare consortium.
- Project location: Barcelona province; contract date: Oct. 8, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.

Canaccord Genuity: Lowers Oklo's target price to $66

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
